Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway

Frontiers in Oncology- Switzerland

doi 10.3389/fonc.2020.00141

Full Text

Abstract

Available in

Date

Authors

Publisher

Frontiers Media SA

Related search

Telmisartan Inhibits NSCLC A549 Cell Proliferation and Migration by Regulating the PI3K/AKT Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2018English

Acetylshikonin Inhibits Colorectal Cancer Growth via PI3K/Akt/mTOR Signaling Pathway

Chinese Medicine
2018English

UNBS5162 Inhibits Colon Cancer Growth via Suppression of PI3K/Akt Signaling Pathway

Medecine/Sciences
BiochemistryMedicineGeneticsMolecular Biology
2018English

BMP9 Inhibits the Growth of Breast Cancer Cells by Downregulation of the PI3K/Akt Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

MicroRNA-145 Inhibits Growth of Laryngeal Squamous Cell Carcinoma by Targeting the PI3K/Akt Signaling Pathway

Cancer Management and Research
Oncology
2019English

MKRN2 Inhibits Migration and Invasion of Non-Small-Cell Lung Cancer by Negatively Regulating the PI3K/Akt Pathway

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2018English

Downregulation of TM7SF4 Inhibits Cell Proliferation and Metastasis of A549 Cells Through Regulating the PI3K/AKT/mTOR Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

PAQR3 Inhibits Proliferation via Suppressing PI3K/AKT Signaling Pathway in Non-Small Cell Lung Cancer

Archives of Medical Science
Medicine
2018English

Lycorine Inhibits Melanoma A375 Cell Growth and Metastasis Through the Inactivation of the PI3K/AKT Signaling Pathway

Medecine/Sciences
BiochemistryMedicineGeneticsMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy